104 related articles for article (PubMed ID: 21539687)
1. Medication-taking behaviours in young adults with schizophrenia: a pilot study.
Lee H; Kane I; Sereika SM; Cho RY; Jolley CJ
J Psychiatr Ment Health Nurs; 2011 Jun; 18(5):418-24. PubMed ID: 21539687
[TBL] [Abstract][Full Text] [Related]
2. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
3. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
4. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators.
Zeller A; Ramseier E; Teagtmeyer A; Battegay E
Hypertens Res; 2008 Nov; 31(11):2037-43. PubMed ID: 19098375
[TBL] [Abstract][Full Text] [Related]
5. Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring.
Tessier A; Dupuy M; Baylé FJ; Herse C; Lange AC; Vrijens B; Schweitzer P; Swendsen J; Misdrahi D
Psychiatry Res; 2020 Mar; 285():112780. PubMed ID: 31954541
[TBL] [Abstract][Full Text] [Related]
6. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
7. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia.
Rungruangsiripan M; Sitthimongkol Y; Maneesriwongul W; Talley S; Vorapongsathorn T
Arch Psychiatr Nurs; 2011 Aug; 25(4):269-83. PubMed ID: 21784285
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level.
Jónsdóttir H; Opjordsmoen S; Birkenaes AB; Engh JA; Ringen PA; Vaskinn A; Aamo TO; Friis S; Andreassen OA
J Clin Psychopharmacol; 2010 Apr; 30(2):169-75. PubMed ID: 20520290
[TBL] [Abstract][Full Text] [Related]
10. Novelty seeking and medication adherence in patients with schizophrenia.
Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
[TBL] [Abstract][Full Text] [Related]
11. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
13. Medication adherence in older renal transplant recipients.
Russell CL; Cetingok M; Hamburger KQ; Owens S; Thompson D; Hathaway D; Winsett RP; Conn VS; Madsen R; Sitler L; Wakefield MR
Clin Nurs Res; 2010 May; 19(2):95-112. PubMed ID: 20185804
[TBL] [Abstract][Full Text] [Related]
14. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
16. Risk profiles for non-adherence to antipsychotic medications.
McCann TV; Boardman G; Clark E; Lu S
J Psychiatr Ment Health Nurs; 2008 Oct; 15(8):622-9. PubMed ID: 18803735
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
19. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
Tsang HW; Fung KM; Corrigan PW
J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
